Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group

This work describes the set-up of a shared platform among the laboratories of the Alleanza Contro il Cancro (ACC) Italian Research Network for the identification of fusion transcripts in sarcomas by using Next Generation Sequencing (NGS). Different NGS approaches, including anchored multiplex PCR and hybrid capture-based panels, were employed to profile a large set of sarcomas of different histotypes. The analysis confirmed the reliability of NGS RNA-based approaches in detecting sarcoma-specific rearrangements. Overall, the anchored multiplex PCR assay proved to be a fast and easy-to-analyze approach for routine diagnostics laboratories.

[1]  T. Shibata,et al.  Expanding the clinicopathologic and molecular spectrum of BCOR‐associated sarcomas in adults , 2020, Histopathology.

[2]  A. Drilon,et al.  Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials. , 2019, The Lancet. Oncology.

[3]  A. Drilon,et al.  Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. , 2019, The Lancet. Oncology.

[4]  B. Haas,et al.  Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods , 2019, Genome Biology.

[5]  M. Ladanyi,et al.  NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls , 2019, Modern Pathology.

[6]  S. Millis,et al.  Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma , 2019, Modern Pathology.

[7]  A. Patchefsky,et al.  Clinical application of RNA sequencing in sarcoma diagnosis , 2019, Medicine.

[8]  R. Kaplan,et al.  New fusion sarcomas: histopathology and clinical significance of selected entities. , 2019, Human pathology.

[9]  J. Choi,et al.  Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies. , 2019, The Journal of molecular diagnostics : JMD.

[10]  J. Mchugh,et al.  Biphenotypic Sinonasal Sarcoma: A Review and Update. , 2018, Archives of pathology & laboratory medicine.

[11]  A. Cleton-Jansen,et al.  Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing. , 2018, The Journal of molecular diagnostics : JMD.

[12]  A. D. Dei Tos,et al.  The pathology of soft tissue sarcomas , 2018, La radiologia medica.

[13]  Barbara Hutter,et al.  PO-400 Arriba – fast and accurate gene fusion detection from RNA-seq data , 2018, ESMO Open.

[14]  J. Blay,et al.  Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. , 2018, The Lancet. Respiratory medicine.

[15]  Jessica L. Davis,et al.  Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. , 2018, The Lancet. Oncology.

[16]  C. Garbutt,et al.  Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications. , 2018, Cancer treatment reviews.

[17]  J. Hornick,et al.  Contemporary Sarcoma Diagnosis, Genetics, and Genomics. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  L. Pachter,et al.  Fusion detection and quantification by pseudoalignment , 2017, bioRxiv.

[19]  A. D. Dei Tos,et al.  HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma , 2017, Genes, chromosomes & cancer.

[20]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[21]  S. Dry,et al.  Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas , 2016, The American journal of surgical pathology.

[22]  C. Antonescu,et al.  Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes , 2016, Genes, chromosomes & cancer.

[23]  Alexander Dobin,et al.  Optimizing RNA-Seq Mapping with STAR. , 2016, Methods in molecular biology.

[24]  R. Maestro,et al.  Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives , 2015, Expert review of anticancer therapy.

[25]  J. Utikal,et al.  Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up , 2013, Clinical Cancer Research.

[26]  B. Bjerkehagen,et al.  Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22‐translocation , 2013, Genes, chromosomes & cancer.

[27]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[28]  O. Delattre,et al.  A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion , 2012, Nature Genetics.

[29]  Margaret King,et al.  State of the art and perspectives , 2004, Machine Translation.

[30]  A. Lowenfels.  A REVIEW AND UPDATE , 1979 .